Prehabilitation to Improve Outcomes of Patients with Gynaecological Cancer: A New Window of Opportunity?
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Criteria for Considering Studies for This Review
2.2. Search Strategy
2.3. Study Selection, Data Extraction and Analysis
2.4. Assessment of Risk of Bias
3. Results
3.1. Study Selection
3.2. Included Studies
3.3. Ovarian Cancer
Prehabilitation Programmes
3.4. Effectiveness of Prehabilitation Programmes
3.5. Endometrial Cancer and Cervical Cancer
Prehabilitation Programmes
3.6. Effectiveness of Prehabilitation Programmes
3.7. Quality of the Studies
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
Appendix A. Search Strategy
References
- Dyba, T.; Randi, G.; Bray, F.; Martos, C.; Giusti, F.; Nicholson, N.; Gavin, A.; Flego, M.; Neamtiu, L.; Dimitrova, N.; et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur. J. Cancer 2021, 157, 308–347. [Google Scholar] [CrossRef] [PubMed]
- Iyer, R.; Gentry-Maharaj, A.; Nordin, A.; Burnell, M.; Liston, R.; Manchanda, R.; Das, N.; Desai, R.; Gornall, R.; Beardmore-Gray, A.; et al. Predictors of complications in gynaecological oncological surgery: A prospective multicentre study (UKGOSOC-UK gynaecological oncology surgical outcomes and complications). Br. J. Cancer 2015, 112, 475–484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Funston, G.; O’Flynn, H.; Ryan, N.A.J.; Hamilton, W.; Crosbie, E.J. Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals. Adv. Ther. 2018, 35, 577–589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hildesheim, A.; Han, C.L.; Brinton, L.A.; Kurman, R.J.; Schiller, J.T. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: Results from a seroepidemiological case-control study. Obstet. Gynecol. 1997, 90, 748–754. [Google Scholar] [CrossRef]
- Smits, A.; Lopes, A.; Das, N.; Kumar, A.; Cliby, W.; Smits, E.; Bekkers, R.; Massuger, L.; Galaal, K. Surgical morbidity and clinical outcomes in ovarian cancer—The role of obesity. BJOG 2016, 123, 300–308. [Google Scholar] [CrossRef]
- Laky, B.; Janda, M.; Cleghorn, G.; Obermair, A. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am. J. Clin. Nutr. 2008, 87, 1678–1685. [Google Scholar] [CrossRef]
- Renehan, A.G.; Tyson, M.; Egger, M.; Heller, R.F.; Zwahlen, M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371, 569–578. [Google Scholar] [CrossRef]
- Bouwman, F.; Smits, A.; Lopes, A.; Das, N.; Pollard, A.; Massuger, L.; Bekkers, R.; Galaal, K. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery--an institutional study and systematic review of the literature. Gynecol. Oncol. 2015, 139, 369–376. [Google Scholar] [CrossRef]
- von Gruenigen, V.E.; Waggoner, S.E.; Frasure, H.E.; Kavanagh, M.B.; Janata, J.W.; Rose, P.G.; Courneya, K.S.; Lerner, E. Lifestyle challenges in endometrial cancer survivorship. Obstet. Gynecol. 2011, 117, 93–100. [Google Scholar] [CrossRef]
- Doll, K.M.; Barber, E.L.; Bensen, J.T.; Revilla, M.C.; Snavely, A.C.; Bennett, A.V.; Reeve, B.B.; Gehrig, P.A. The impact of surgical complications on health-related quality of life in women undergoing gynecologic and gynecologic oncology procedures: A prospective longitudinal cohort study. Am. J. Obstet. Gynecol. 2016, 215, 457.e1–457.e13. [Google Scholar] [CrossRef] [Green Version]
- Kohut, A.; Earnhardt, M.C.; Cuccolo, N.G.; Kim, C.S.; Song, M.; Girda, E.; De Meritens, A.B.; Stephenson, R.; Balica, A.; Leiser, A.; et al. Evaluating unplanned readmission and prolonged length of stay following minimally invasive surgery for endometrial cancer. Gynecol. Oncol. 2020, 156, 162–168. [Google Scholar] [CrossRef] [Green Version]
- Wright, J.D.; Herzog, T.J.; Neugut, A.I.; Burke, W.M.; Lu, Y.S.; Lewin, S.N.; Hershman, D.L. Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer. Obstet. Gynecol. 2012, 120, 871–881. [Google Scholar] [CrossRef]
- Bisch, S.P.; Jago, C.A.; Kalogera, E.; Ganshorn, H.; Meyer, L.A.; Ramirez, P.T.; Dowdy, S.C.; Nelson, G. Outcomes of enhanced recovery after surgery (ERAS) in gynecologic oncology—A systematic review and meta-analysis. Gynecol. Oncol. 2021, 161, 46–55. [Google Scholar] [CrossRef]
- Nelson, G.; Bakkum-Gamez, J.; Kalogera, E.; Glaser, G.; Altman, A.; Meyer, L.A.; Taylor, J.S.; Iniesta, M.; Lasala, J.; Mena, G.; et al. Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations-2019 update. Int. J. Gynecol. Cancer. 2019, 29, 651–668. [Google Scholar] [CrossRef]
- de Groot, J.J.A.; Maessen, J.M.C.; Dejong, C.H.C.; Winkens, B.; Kruitwagen, R.; Slangen, B.F.M.; van der Weijden, T. Interdepartmental Spread of Innovations: A Multicentre Study of the Enhanced Recovery After Surgery Programme. World J. Surg. 2018, 42, 2348–2355. [Google Scholar] [CrossRef] [Green Version]
- Banugo, P. Prehabilitation. BJA Education 2017, 17, 401–405. [Google Scholar] [CrossRef] [Green Version]
- Lambert, J.E.; Hayes, L.D.; Keegan, T.J.; Subar, D.A.; Gaffney, C.J. The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis. Ann. Surg. 2021, 274, 70–77. [Google Scholar] [CrossRef]
- Waterland, J.L.; McCourt, O.; Edbrooke, L.; Granger, C.L.; Ismail, H.; Riedel, B.; Denehy, L. Efficacy of Prehabilitation Including Exercise on Postoperative Outcomes Following Abdominal Cancer Surgery: A Systematic Review and Meta-Analysis. Front. Surg. 2021, 8, 628848. [Google Scholar] [CrossRef]
- Bruns, E.R.; van den Heuvel, B.; Buskens, C.J.; van Duijvendijk, P.; Festen, S.; Wassenaar, E.B.; van der Zaag, E.S.; Bemelman, W.A.; van Munster, B.C. The effects of physical prehabilitation in elderly patients undergoing colorectal surgery: A systematic review. Colorectal Dis. 2016, 18, O267–O277. [Google Scholar] [CrossRef]
- Berkel, A.E.M.; Bongers, B.C.; Kotte, H.; Weltevreden, P.; de Jongh, F.H.C.; Eijsvogel, M.M.M.; Wymenga, M.; Bigirwamungu-Bargeman, M.; van der Palen, J.; van Det, M.J.; et al. Effects of Community-based Exercise Prehabilitation for Patients Scheduled for Colorectal Surgery with High Risk for Postoperative Complications: Results of a Randomized Clinical Trial. Ann. Surg. 2022, 275, e299–e306. [Google Scholar] [CrossRef]
- de Klerk, M.; van Dalen, D.H.; Nahar-van Venrooij, L.M.W.; Meijerink, W.; Verdaasdonk, E.G.G. A multimodal prehabilitation program in high-risk patients undergoing elective resection for colorectal cancer: A retrospective cohort study. Eur. J. Surg. Oncol. 2021, 47, 2849–2856. [Google Scholar] [CrossRef]
- Page, M.J.; Moher, D.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. BMJ 2021, 372, n160. [Google Scholar] [CrossRef]
- Sterne, J.A.; Hernan, M.A.; Reeves, B.C.; Savovic, J.; Berkman, N.D.; Viswanathan, M.; Henry, D.; Altman, D.G.; Ansari, M.T.; Boutron, I.; et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016, 355, i4919. [Google Scholar] [CrossRef] [Green Version]
- Aromataris, E.; Fernandez, R.; Godfrey, C.M.; Holly, C.; Khalil, H.; Tungpunkom, P. Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. Int. J. Evid.-Based Healthc. 2015, 13, 132–140. [Google Scholar] [CrossRef] [Green Version]
- Arnaboldi, P.; Santoro, L.; Mazzocco, K.; Oliveri, S.; Maggioni, A.; Pravettoni, G. The Paradox of Pelvic Exenteration: The Interaction of Clinical and Psychological Variables. Int. J. Gynecol. Cancer 2015, 25, 1534–1540. [Google Scholar] [CrossRef]
- Hertlein, L.; Zeder-Göß, C.; Fürst, S.; Bayer, D.; Trillsch, F.; Czogalla, B.; Mahner, S.; Burges, A.; Rittler, P. Peri-operative oral immunonutrition in malnourished ovarian cancer patients assessed by the nutritional risk screening. Arch. Gynecol. Obstet. 2018, 297, 1533–1538. [Google Scholar] [CrossRef]
- Seibaek, L.; Blaakaer, J.; Petersen, L.K.; Hounsgaard, L. Ovarian cancer surgery: Health and coping during the perioperative period. Support Care Cancer 2013, 21, 575–582. [Google Scholar] [CrossRef]
- Diaz-Feijoo, B.; Agusti-Garcia, N.; Sebio, R.; Lopez-Hernandez, A.; Siso, M.; Glickman, A.; Carreras-Dieguez, N.; Fuste, P.; Marina, T.; Martinez-Egea, J.; et al. Feasibility of a Multimodal Prehabilitation Programme in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study. Cancers 2022, 14, 1635. [Google Scholar] [CrossRef]
- Aubrey, C.; Skeldon, M.; Chapelsky, S.; Giannakopoulos, N.; Ghosh, S.; Steed, H.; Pin, S. Preoperative weight loss in women with obesity in gynaecologic oncology: A retrospective study. Clin. Obes. 2021, 11, e12445. [Google Scholar] [CrossRef]
- Fernandez-Candela, A.; Calero, A.; Sanchez-Guillen, L.; Escrig-Sos, J.; Barreras, J.A.; Lopez-Rodriguez, F.; Armananzas, L.; Murcia, A.; Arroyo, A.; Lacueva, F.J.; et al. Effect of preoperative immunonutrition on postoperative major morbidity after cytoreductive surgery and hipec in patients with peritoneal metastasis. Nutrients 2021, 13, 2147. [Google Scholar] [CrossRef]
- Carli, F.; Brown, R.; Kennepohl, S. Prehabilitation to enhance postoperative recovery for an octogenarian following robotic-assisted hysterectomy with endometrial cancer. Can. J. Anaesth. 2012, 59, 779–784. [Google Scholar] [CrossRef] [PubMed]
- Diaz-Feijoo, B.; Agusti, N.; Sebio, R.; Lopez-Hernandez, A.; Siso, M.; Torne, A.; Martinez-Palli, G.; Arguis, M. Feasibility of a Multimodal Prehabilitation Program in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer: A Pilot Study. Res. Sq. 2021; Epub ahead of printing. [Google Scholar] [CrossRef]
- Miralpeix, E.; Sole-Sedeno, J.M.; Rodriguez-Cosmen, C.; Taus, A.; Muns, M.D.; Fabrego, B.; Mancebo, G. Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: A pilot study. World J. Surg. Oncol. 2022, 20, 46. [Google Scholar] [CrossRef] [PubMed]
- Bousquet-Dion, G.; Awasthi, R.; Loiselle, S.E.; Minnella, E.M.; Agnihotram, R.V.; Bergdahl, A.; Carli, F.; Scheede-Bergdahl, C. Evaluation of supervised multimodal prehabilitation programme in cancer patients undergoing colorectal resection: A randomized control trial. Acta Oncol. 2018, 57, 849–859. [Google Scholar] [CrossRef] [Green Version]
- Daniels, S.L.; Lee, M.J.; George, J.; Kerr, K.; Moug, S.; Wilson, T.R.; Brown, S.R.; Wyld, L. Prehabilitation in elective abdominal cancer surgery in older patients: Systematic review and meta-analysis. BJS Open. 2020, 4, 1022–1041. [Google Scholar] [CrossRef]
- Lauridsen, S.V.; Thomsen, T.; Jensen, J.B.; Kallemose, T.; Schmidt Behrend, M.; Steffensen, K.; Poulson, A.M.; Jacobsen, A.; Walther, A.; Isaksson, A.; et al. Effect of a Smoking and Alcohol Cessation Intervention Initiated Shortly Before Radical Cystectomy-the STOP-OP Study: A Randomised Clinical Trial. Eur. Urol. Focus. 2022. [Google Scholar] [CrossRef]
- Jensen, B.T.; Laustsen, S.; Jensen, J.B.; Borre, M.; Petersen, A.K. Exercise-based pre-habilitation is feasible and effective in radical cystectomy pathways-secondary results from a randomized controlled trial. Support Care Cancer 2016, 24, 3325–3331. [Google Scholar] [CrossRef]
- Kaye, D.R.; Schafer, C.; Thelen-Perry, S.; Parker, C.; Iglay-Reger, H.; Daignault-Newton, S.; Qin, Y.; Morgan, T.M.; Weizer, A.Z.; Kaffenberger, S.D.; et al. The Feasibility and Impact of a Presurgical Exercise Intervention Program (Prehabilitation) for Patients Undergoing Cystectomy for Bladder Cancer. Urology 2020, 145, 106–112. [Google Scholar] [CrossRef]
- Minnella, E.M.; Awasthi, R.; Bousquet-Dion, G.; Ferreira, V.; Austin, B.; Audi, C.; Tanguay, S.; Aprikian, A.; Carli, F.; Kassouf, W. Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial. Eur. Urol. Focus. 2021, 7, 132–138. [Google Scholar] [CrossRef]
- Geoffrion, R.K.N.; Koenig, N.A.; Zheng, M.; Sinclair, N.; Brotto, L.A.; Lee, T. Preoperative Depression and Anxiety Impact on Inpatient Surgery Outcomes: A Prospective Cohort Study. Ann. Surg. Open 2021, 2, e049. [Google Scholar] [CrossRef]
- Kathiresan, A.S.; Brookfield, K.F.; Schuman, S.I.; Lucci, J.A., 3rd. Malnutrition as a predictor of poor postoperative outcomes in gynecologic cancer patients. Arch. Gynecol. Obstet. 2011, 284, 445–451. [Google Scholar] [CrossRef]
- Orekoya, O.; Samson, M.E.; Trivedi, T.; Vyas, S.; Steck, S.E. The Impact of Obesity on Surgical Outcome in Endometrial Cancer Patients: A Systematic Review. J. Gynecol. Surg. 2016, 32, 149–157. [Google Scholar] [CrossRef] [Green Version]
- Biller, V.S.; Leitzmann, M.F.; Sedlmeier, A.M.; Berger, F.F.; Ortmann, O.; Jochem, C. Sedentary behaviour in relation to ovarian cancer risk: A systematic review and meta-analysis. Eur. J. Epidemiol. 2021, 36, 769–780. [Google Scholar] [CrossRef]
- Moore, S.C.; Gierach, G.L.; Schatzkin, A.; Matthews, C.E. Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br. J. Cancer 2010, 103, 933–938. [Google Scholar] [CrossRef] [Green Version]
- Felix, A.S.; Bower, J.K.; Pfeiffer, R.M.; Raman, S.V.; Cohn, D.E.; Sherman, M.E. High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database. Int. J. Cancer 2017, 140, 555–564. [Google Scholar] [CrossRef]
- Shinn, E.H.; Lenihan, D.J.; Urbauer, D.L.; Basen-Engquist, K.M.; Valentine, A.; Palmero, L.; Woods, M.L.; Patel, P.; Nick, A.M.; Shahzad, M.M.; et al. Impact of cardiovascular comorbidity on ovarian cancer mortality. Cancer Epidemiol. Biomark. Prev. 2013, 22, 2102–2109. [Google Scholar] [CrossRef] [Green Version]
- Smits, A.; Lopes, A.; Bekkers, R.; Galaal, K. Body mass index and the quality of life of endometrial cancer survivors--a systematic review and meta-analysis. Gynecol. Oncol. 2015, 137, 180–187. [Google Scholar] [CrossRef]
- Nordhausen, K.; Solass, W.; Demtroeder, C.; Tempfer, C.B.; Reymond, M. Cachexia-anorexia syndrome in patients with peritoneal metastasis: An observational study. Pleura Peritoneum 2016, 1, 57–63. [Google Scholar] [CrossRef] [Green Version]
- Zabora, J.; BrintzenhofeSzoc, K.; Curbow, B.; Hooker, C.; Piantadosi, S. The prevalence of psychological distress by cancer site. Psychooncology 2001, 10, 19–28. [Google Scholar] [CrossRef]
- Campbell, K.L.; Winters-Stone, K.M.; Wiskemann, J.; May, A.M.; Schwartz, A.L.; Courneya, K.S.; Zucker, D.S.; Matthews, C.E.; Ligibel, J.A.; Gerber, L.H.; et al. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med. Sci. Sports Exerc. 2019, 51, 2375–2390. [Google Scholar] [CrossRef] [Green Version]
- Turner, R.R.; Steed, L.; Quirk, H.; Greasley, R.U.; Saxton, J.M.; Taylor, S.J.; Rosario, D.J.; Thaha, M.A.; Bourke, L. Interventions for promoting habitual exercise in people living with and beyond cancer. Cochrane Database Syst. Rev. 2018, 9, CD010192. [Google Scholar] [CrossRef] [PubMed]
- NHS. Delivering Cancer Waiting Times. A Good Practice Guide. Available online: https://www.england.nhs.uk/wp-content/uploads/2015/03/delivering-cancer-wait-times.pdf (accessed on 21 February 2022).
- Specialisten, F.M. Multidisciplinaire Normering Oncologische Zorg in Nederland. 2021. Available online: https://www.soncos.org/wp-content/uploads/2021/03/SONCOS-normeringsrapport-versie-9-2021.pdf (accessed on 21 February 2022).
- Tseng, J.H.; Roche, K.L.; Jernigan, A.M.; Salani, R.; Bristow, R.E.; Fader, A.N. Lifestyle and Weight Management Counseling in Uterine Cancer Survivors: A Study of the Uterine Cancer Action Network. Int. J. Gynecol. Cancer 2015, 25, 1285–1291. [Google Scholar] [CrossRef] [PubMed]
- Stull, V.B.; Snyder, D.C.; Demark-Wahnefried, W. Lifestyle interventions in cancer survivors: Designing programs that meet the needs of this vulnerable and growing population. J. Nutr. 2007, 137, 243S–248S. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ward, K.K.; Shah, N.R.; Saenz, C.C.; McHale, M.T.; Alvarez, E.A.; Plaxe, S.C. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol. Oncol. 2012, 126, 176–179. [Google Scholar] [CrossRef]
- Kokts-Porietis, R.L.; Elmrayed, S.; Brenner, D.R.; Friedenreich, C.M. Obesity and mortality among endometrial cancer survivors: A systematic review and meta-analysis. Obes. Rev. 2021, 22, e13337. [Google Scholar] [CrossRef]
- Hansen, J.M.; Nagle, C.M.; Ibiebele, T.I.; Grant, P.T.; Obermair, A.; Friedlander, M.L.; DeFazio, A.; Webb, P.M. A healthy lifestyle and survival among women with ovarian cancer. Int. J. Cancer. 2020, 147, 3361–3369. [Google Scholar] [CrossRef]
Study | Country Year | Study Design | Population (n) Age (years) | Cancer Type | Type of Programme and Duration | Outcome Measures | Outcomes |
---|---|---|---|---|---|---|---|
Diaz-Feijoo [28] | Spain, 2021 | Prospective vs. retrospective cohort | n = 34 IG: 15 CG: 19 Age (median): IG: 55 CG: 60 | Ovarian: 34 | Physical therapy Nutrition Psychological therapy 2 weeks or more | Postoperative complications (Clavien–Dindo) Hospital stay Time until chemotherapy Compliance | Hospital stay: 5 vs. 7 days (IG vs. CG) *. Time until chemotherapy: 25 vs. 35 days (IG vs. CG) *. ICU stay NS Complications: NS Compliance: 80% No adverse events |
Fernández-Candela [30] | Spain, 2021 | Retrospective cohort | n = 107 IG: 48 CG: 59 Age (median): 60 | Ovarian: 53 Colorectal: 32 Pseudomyxoma: 13 Others: 9 | Nutrition (Atempero R) 7 days | Postoperative complications (Clavien–Dindo) Hospital stay CRP Adherence | More visceral resections in IG * (>2 in 73% IG vs. 27% CG) Less HIPEC given in IG * Complications: NS Immunonutrition is independent protective factor for postoperative complications * (OR 0.247; 95%CI 0.071–0.859) Overall complications: NS Hospital stay: NS CRP: NS No adverse events |
Hertlein [26] | Germany, 2018 | Prospective cohort | n = 47 IG: 28 CG: 19 Age (median): IG: 70 CG: 68 | Ovarian: 47 | Nutrition (Impact R) 10 days (5 preoperative) | Postoperative complications Length of stay Compliance | Postoperative complications: NS Length of stay: NS Preoperative compliance: 78.6% Postoperative compliance: 28.5% No adverse events |
Seibaek [27] | Denmark, 2012 | Prospective cohort | n = 145 IG: 55 CG: 90 Age (mean): IG: 63 CG: 58 | Ovarian: 109 Benign: 36 | Physical therapy Nutrition Psychological therapy Smoking cessation Duration: unknown | Quality of life (SF-36) Coping (SOC) | Higher physical functioning: CG vs. IG (8.58 points) * Other quality of life outcomes: NS Coping: NS |
Study | Country Year | Study Design | Population (n) Age (years) | Cancer Type | Type of Programme and Duration | Outcome Measures | Outcomes |
---|---|---|---|---|---|---|---|
Arnaboldi [25] | Italy, 2015 | Prospective cohort | n = 49 IG: 17 CG: 32 Age (median): 54 | Cervix: 29 Endometrial: 7 Peritoneal: 1 Fallopian: 3 Vagina: 7 Vulva: 2 | Psychological therapy Duration: unknown | Postoperative pain (VAS) Hospital stay | Postoperative pain: NS Hospital stay: NS |
Aubrey [29] | Canada, 2021 | Retrospective cohort | n = 48 IG: A: n = 39 B: n = 3 C: n = 6 Age (mean): 58 | Endometrial: 31 Hyperplasia: 7 Adnexal mass: 7 Other: 4 | Nutrition 12 weeks to 6 months | Weight loss Surgical time Blood loss Conversion Hospital stay | Mean weight loss 12.0 kg (9.7%) * Other surgical outcomes: NS Hospital stay: NS |
Carli [31] | Canada, 2012 | Case report | n = 1 Age: 88 | Endometrial | Physical therapy Nutrition 3 weeks | Exercise tolerance (6 MWT) Cognitive function (RBANS) Quality of life (SF-36) Perioperative complications | Increased 6 MWT (91.2 m to 144.8 m) Cognitive function: RBANS increased from 58 (<1st percentile) to 81 (10 percentile) Improvements in both mental and physical components of SF-36 No complications No adverse events |
Confounding | Selection of Participants | Classification of Interventions | Deviations from Intended Interventions | Missing Data | Measurement of Outcomes | Selection of Reported Results | |
---|---|---|---|---|---|---|---|
Arnaboldi [25] | |||||||
Aubrey [29] | |||||||
Diaz-Feijoo [28] | |||||||
Fernández-Candea [30] | |||||||
Hertlein [26] | |||||||
Seibaek [27] |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Dhanis, J.; Keidan, N.; Blake, D.; Rundle, S.; Strijker, D.; van Ham, M.; Pijnenborg, J.M.A.; Smits, A. Prehabilitation to Improve Outcomes of Patients with Gynaecological Cancer: A New Window of Opportunity? Cancers 2022, 14, 3448. https://doi.org/10.3390/cancers14143448
Dhanis J, Keidan N, Blake D, Rundle S, Strijker D, van Ham M, Pijnenborg JMA, Smits A. Prehabilitation to Improve Outcomes of Patients with Gynaecological Cancer: A New Window of Opportunity? Cancers. 2022; 14(14):3448. https://doi.org/10.3390/cancers14143448
Chicago/Turabian StyleDhanis, Joëlle, Nathaniel Keidan, Dominic Blake, Stuart Rundle, Dieuwke Strijker, Maaike van Ham, Johanna M. A. Pijnenborg, and Anke Smits. 2022. "Prehabilitation to Improve Outcomes of Patients with Gynaecological Cancer: A New Window of Opportunity?" Cancers 14, no. 14: 3448. https://doi.org/10.3390/cancers14143448